Biotech

All Articles

Daiichi pays out Merck $170M to form lung cancer T-cell engager deal

.Merck &amp Co. has actually rapidly recouped a few of the costs of its own Harpoon Rehabs acquistio...

BioMarin standstills preclinical gene treatment for heart disease

.After BioMarin administered a spring clean of its own pipe in April, the company has made a decisio...

Eisai vegetations molecular adhesive SEED with $1.5 B biobucks work

.Major Pharmas continue to be caught to the idea of molecular glue degraders. The most up to date bu...

Life scientific research credit report firm unveils along with $600M

.A brand new international lifestyle science credit history firm, termed Symbiotic Financing, has br...

BMS channels TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another major wager coming from the Caforio period, term...

Nuvation standstills wager inhibitor after thinking about phase 1 record

.After having a look at stage 1 information, Nuvation Biography has decided to stop deal with its on...

' Clinical intuition' led FDA experts to support Zevra's unusual disease med

.Zevra Therapies' unusual illness medicine seems to become on the path to confirmation this loss aft...

Pfizer takes $230M struck after axing fell short DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has actually gone a $23...

AC Immune observes 'landmark' prospective in Alzheimer's medication data

.After greater than two decades of work with neurodegenerative illness, Swiss biotech a/c Immune cas...

GSK loses ph. 2 HPV vaccine over lack of best-in-class prospective

.GSK has actually scrapped a period 2 human papillomavirus (HPV) injection coming from its pipe afte...